Photo: Shutterstock
Insys, the manufacturer of the fentanyl drug Subsys, used most commonly for cancer patients, encouraged doctors to prescribe the painkiller for uses other than those approved by the FDA, Aetna alleged.
August 28, 2018 at 12:42 PM
1 minute read
A federal judge has declined to toss out a lawsuit in which Aetna alleged the maker of a highly addictive opioid-based painkiller duped the insurance company into paying reimbursements for off-label uses.
In an Aug. 23 ruling, U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania denied defendant Insys Therapeutic’s request to dismiss the case.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
